Dallas, TX -- (SBWIRE) -- 05/27/2015 -- The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key peripheral vascular stents pipeline products. Complete report with 172 market data tables and 6 figures, spread across 213 pages is available at http://www.rnrmarketresearch.com/peripheral-vascular-stents-pipeline-review-2015-market-report.html

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Peripheral Vascular Stents products under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Companies discussed in this report includes: 3D Biotek, LLC, Abbott Vascular Inc., Andramed GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, Contego Medical, LLC, Cook Medical Incorporated, Cordis Corporation, CorInnova, Inc., Cytograft Tissue Engineering, Inc., Elixir Medical Corporation, HEXACATH, InspireMD, Inc., Lifetech Scientific (Shenzhen) Co., Ltd., MicroVention, Inc., Nipro Corporation, NSVascular, Inc., Palmaz Scientific, Inc., Stentys, SA, Stron Medical, Taewoong Medical Co.,Ltd., Tepha, Inc., Terumo Corporation, University of Texas Medical Branch at Galveston, Veniti, Inc., Veryan Medical Limited, VueKlar Cardiovascular Ltd., W. L. Gore & Associates, Inc.

Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=386498

(This is a premium report priced at US$4000 for a single user License.)

Reasons to buy

The report enables you to –

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Peripheral Vascular Stents under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

Explore more reports on Medical Devices at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices